Dutch insurers get biosimilars green light
05 August 2009
Francesca Bruce
Please Login to read the full article.
05 August 2009
Francesca Bruce
Health insurers in the Netherlands can include biosimilars in their preference policies, the Dutch health ministry has confirmed for the first time, signalling Europe's growing acceptance of these products.
The clarification came at a recent parliamentary question-and-answer session...
Please Login to read the full article.
RELATED CONTENT
NEWS
- FDA panel backs Regeneron wet AMD drug, all eyes on pricing
- France votes for more regulatory transparency, tighter safety monitoring and tougher promotion controls
- US Capitol Capsule: Supreme Court takes another stab at refining US patent law
- YM BioSciences rises on PhI/II results showing promise for JAK1/JAK2 inhibitor for myelofibrosis
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
